Left Atrial Strain for Predicting MACE in NSTEMI

Trial statusNot yet recruiting
Trial phaseNot listed
Trial typeObservational
Biological sexAll
Age18+
SponsorAssiut University

About this trial

This prospective observational study aims to evaluate whether left atrial reservoir strain, measured by two-dimensional speckle tracking echocardiography, independently predicts 6-month major adverse cardiovascular events (MACE) and provides incremental prognostic value beyond the GRACE 2.0 score, left ventricular ejection fraction, and left atrial volume index in patients with non-ST-elevation myocardial infarction.

Eligibility criteria

This trial does not accept healthy volunteers

Qualifiers

Age > 18 years

Confirmed diagnosis of NSTEMI according to current ESC/ACC guidelines

Willingness to provide informed consent and complete 6-month follow-up

Undergoing coronary angiography or revascularization during the index hospitalization

Disqualifiers

ST-elevation myocardial infarction (STEMI)

Atrial fibrillation or other significant arrhythmia at presentation

Moderate to severe valvular heart disease (especially mitral valve disease)

Prior cardiac surgery or valve replacement

Trial population

Adult patients admitted with NSTEMI to the Cardiology Department / Coronary Care Unit of Assiut University Hospital who meet the eligibility criteria.

Trial design

Design model

Cohort

Time perspective

Prospective

Treatments tested in this trial

Not listed

Trial groups

No trial groups listed

Trial outcomes

Primary outcomes

1

6-month major adverse cardiovascular events (MACE)

Composite of cardiac death, recurrent myocardial infarction, heart failure hospitalization, or life-threatening arrhythmia occurring within 6 months of admission.

Time frame
6 months

Secondary outcomes

1

Left atrial reservoir strain

Peak atrial longitudinal strain (PALS) during the reservoir phase measured by two-dimensional speckle tracking echocardiography (EchoPAC software), expressed as percentage (%). Higher values indicate better left atrial function.

Time frame
Baseline
2

Change in risk discrimination with addition of LA reservoir strain

Change in risk discrimination for 6-month MACE when left atrial reservoir strain is added to the GRACE 2.0 score, left ventricular ejection fraction (LVEF), and left atrial volume index (LAVI), assessed by change in C-statistic, Net Reclassification Improvement (NRI), and Integrated Discrimination Improvement (IDI).

Time frame
6 months
3

Optimal cutoff value of LA reservoir strain

Optimal cutoff value of left atrial reservoir strain for predicting 6-month MACE determined by receiver operating characteristic (ROC) curve analysis.

Time frame
6 months
4

Correlation of LA reservoir strain with clinical parameters

Correlation between left atrial reservoir strain (expressed as percentage) and the following parameters: GRACE 2.0 score, peak troponin level (ng/L), left ventricular ejection fraction (%), and E/e' ratio. Correlation will be assessed using Pearson or Spearman correlation coefficient.

Time frame
Baseline

Other outcomes

Locations

This trial has no locations.

Sponsors and contacts

Click on the lead sponsor to view all of their trials.

This trial is not recruiting at the moment. You can still explore other options: